{
    "Trade/Device Name(s)": [
        "Rapidan Optima Early Pregnancy Test",
        "Toyo Pregnancy Test",
        "Rapidan Optima Early One Step hCG Urine Pregnancy Test",
        "Toyo One Step hCG Urine Pregnancy Test"
    ],
    "Submitter Information": "Turklab Tibbi Malzemeler San. ve Tic. A.S.",
    "510(k) Number": "K081150",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043443"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX",
        "JHI"
    ],
    "Summary Letter Date": "May 29, 2009",
    "Summary Letter Received Date": "June 03, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Immunochromatography"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test",
        "Strip",
        "Cassette"
    ],
    "Document Summary": "FDA 510(k) summary for Rapidan Optima Early and Toyo One Step hCG Urine Pregnancy Tests using chromatographic immunoassay to qualitatively detect hCG in urine for pregnancy detection.",
    "Indications for Use Summary": "In vitro diagnostic tests for qualitative detection of hCG in human urine to aid in pregnancy detection; Rapidan Optima Early for OTC use (cut-off 20 IU/L); Toyo for OTC and professional/lab use (cut-off 25 IU/L), available in cassette and strip formats.",
    "fda_folder": "Clinical Chemistry"
}